SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001356576-19-000015
Filing Date
2019-07-23
Accepted
2019-07-23 17:20:07
Documents
16
Period of Report
2019-07-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k2q19earningsreleas.htm   iXBRL 8-K 46422
2 EXHIBIT 1.99.1 ex9917-23x19.htm EX-1.99.1 9621
8 logoa03.jpg GRAPHIC 5496
  Complete submission text file 0001356576-19-000015.txt   207655

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20190723.xsd EX-101.SCH 4582
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20190723_cal.xml EX-101.CAL 620
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20190723_def.xml EX-101.DEF 1470
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20190723_lab.xml EX-101.LAB 26141
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20190723_pre.xml EX-101.PRE 13576
9 EXTRACTED XBRL INSTANCE DOCUMENT a8-k2q19earningsreleas_htm.xml XML 4224
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 19968472
SIC: 2834 Pharmaceutical Preparations